We then systematically investigated signaling pathways by gene set enrichment analysis (GSEA) of ARID1A mRNA levels in the TCGA-CRC dataset to identify which gene signatures might be targeted to increase the therapeutic efficacy of radiotherapy in ARID1A-low CRC. Here, ARID1A is linked to colorectal carcinoma.